Charles Schwab’s Lineage Cell Therapeutics LCTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $369K | Buy |
|
|||||
|
2025
Q2 | $62K | Sell |
|
|||||
|
2025
Q1 | $227K | Buy |
|
|||||
|
2024
Q4 | $209K | Hold |
|
|||||
|
2024
Q3 | $377K | Sell |
|
|||||
|
2024
Q2 | $415K | Buy |
|
|||||
|
2024
Q1 | $542K | Buy |
|
|||||
|
2023
Q4 | $396K | Hold |
|
|||||
|
2023
Q3 | $429K | Hold |
|
|||||
|
2023
Q2 | $512K | Buy |
|
|||||
|
2023
Q1 | $102K | Buy |
|
|||||
|
2022
Q4 | $53.3K | Hold |
|
|||||
|
2022
Q3 | $52K | Hold |
|
|||||
|
2022
Q2 | $72K | Sell |
|
|||||
|
2022
Q1 | $512K | Buy |
|
|||||
|
2021
Q4 | $773K | Hold |
|
|||||
|
2021
Q3 | $795K | Sell |
|
|||||
|
2021
Q2 | $919K | Buy |
|
|||||
|
2021
Q1 | $114K | Sell |
|
|||||
|
2020
Q4 | $117K | Hold |
|
|||||
|
2020
Q3 | $62K | Hold |
|
|||||
|
2020
Q2 | $58K | Sell |
|
|||||
|
2020
Q1 | $194K | Hold |
|
|||||
|
2019
Q4 | $208K | Hold |
|
|||||
|
2019
Q3 | $230K | Hold |
|
|||||
|
2019
Q2 | $258K | Hold |
|
|||||
|
2019
Q1 | $307K | Sell |
|
|||||
|
2018
Q4 | $216K | Buy |
|
|||||
|
2018
Q3 | $482K | Buy |
|
|||||
|
2018
Q2 | $359K | Hold |
|
|||||
|
2018
Q1 | $468K | Buy |
|
|||||
|
2017
Q4 | $310K | Buy |
|
|||||
|
2017
Q3 | $300K | Sell |
|
|||||
|
2017
Q2 | $514K | Buy |
|
|||||
|
2017
Q1 | $371K | Hold |
|
|||||
|
2016
Q4 | $389K | Hold |
|
|||||
|
2016
Q3 | $420K | Buy |
|
|||||
|
2016
Q2 | $218K | Hold |
|
|||||
|
2016
Q1 | $240K | Sell |
|
|||||
|
2015
Q4 | $343K | Hold |
|
|||||
|
2015
Q3 | $251K | Hold |
|
|||||
|
2015
Q2 | $304K | Hold |
|
|||||
|
2015
Q1 | $415K | Hold |
|
|||||
|
2014
Q4 | $312K | Hold |
|
|||||
|
2014
Q3 | $263K | Hold |
|
|||||
|
2014
Q2 | $255K | Buy |
|
|||||
|
2014
Q1 | $168K | Hold |
|
|||||
|
2013
Q4 | $184K | Hold |
|
|||||
|
2013
Q3 | $201K | Sell |
|
|||||
|
2013
Q2 | $289K | Buy |
|